IMPACT OF FIXED-DOSE 4F-PCC ON TIME TO ADMINISTRATION FOR ANTICOAGULATION REVERSAL IN THE ED

被引：0
|
作者：
DeFilippo, Nicholas [1 ]
Jones, Kerri [1 ]
Pournezhad, Sam [2 ]
Patka, John [1 ]
Chester, Katleen [2 ]
Morrison, Christopher [1 ]
机构：
[1] Grady Mem Hosp, Atlanta, GA USA
[2] Grady Hlth Syst, Emeryville, CA USA
来源：
CRITICAL CARE MEDICINE | 2023年 / 51卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
1007
引用
收藏
页码：497 / 497
页数：1
相关论文
共 50 条
  • [31] Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors
    Jing Tao
    Elena N. Bukanova
    Shamsuddin Akhtar
    Journal of Intensive Care, 6
  • [32] Pharmacometric modeling to explore 4F-PCC dosing strategies for VKA reversal in patients with INR below 2
    Sarode, Ravi
    Fukutake, Katsuyuki
    Yasaka, Masahiro
    Tortorici, Michael A.
    Mangione, Antoinette
    Pfister, Marc
    Cuker, Adam
    BLOOD ADVANCES, 2020, 4 (17) : 4208 - 4216
  • [33] EFFICACY AND SAFETY OF 4F-PCC VS. FFP FOR WARFARIN REVERSAL IN EMERGENT SURGERY/INVASIVE PROCEDURE
    Mazur, Hannah
    Young, Sarah
    McGraw, Molly
    Montepara, Courtney
    CRITICAL CARE MEDICINE, 2019, 47
  • [34] 4F-PCC was noninferior to plasma in patients with acute major bleeding who needed urgent VKA reversal
    Lang, Eddy
    ANNALS OF INTERNAL MEDICINE, 2014, 160 (08)
  • [35] FIXED-DOSE 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE FOR WARFARIN REVERSAL
    Gomez, Leigh
    Langenhan, Emilie
    Blaha, Madeline
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 379 - 379
  • [36] IMPACT OF OBESITY ON WARFARIN REVERSAL WITH FIXED-DOSE FACTOR EIGHT INHIBITOR BYPASSING ACTIVITY
    McKinney, Amanda
    Dailey, Lindsey
    McMillen, James
    Rowe, A. Shaun
    CRITICAL CARE MEDICINE, 2020, 48
  • [37] 4-FACTOR PCC DOSING IN PATIENTS ON DOAC OR WARFARIN: SUPPORT FOR A FIXED-DOSE PROTOCOL
    Lindsey, Lindsey
    Etter, Elaina
    Morrison, Christopher
    Curry, Marjorie
    Chester, Katleen
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 311 - 311
  • [38] Emergent Warfarin Reversal With Fixed-Dose 4-Factor Prothrombin Complex Concentrate
    Jansma, Brianna
    Montgomery, Josephine
    Dietrich, Scott
    Mixon, Mark A.
    Peksa, Gary D.
    Faine, Brett
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (11) : 1090 - 1095
  • [39] Efficacy and Safety of the Fixed-Dose Versus Variable-Dose of 4-PCC for Vitamin K Antagonist Reversal: A Comprehensive Systematic Review and Meta-Analysis
    Mohammadi, Keyhan
    Yaribash, Shakila
    Sani, Mahmood Alizadeh
    Talasaz, Azita Hajhossein
    CARDIOVASCULAR DRUGS AND THERAPY, 2022, 36 (03) : 533 - 546
  • [40] Efficacy and Safety of the Fixed-Dose Versus Variable-Dose of 4-PCC for Vitamin K Antagonist Reversal: A Comprehensive Systematic Review and Meta-Analysis
    Keyhan Mohammadi
    Shakila Yaribash
    Mahmood Alizadeh Sani
    Azita Hajhossein Talasaz
    Cardiovascular Drugs and Therapy, 2022, 36 : 533 - 546
12345